Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding

Behavioural Pharmacology
Richard J BeningerJames N Reynolds

Abstract

Phencyclidine (PCP), an antagonist at the N-methyl-D-aspartate subtype of ionotropic glutamatergic receptors, decreases gamma-aminobutyric acid (GABA)ergic inhibition, suggesting that changes in GABAergic receptor function underlie behavioral and cognitive deficits resulting from repeated administration of PCP. To test this hypothesis, male Sprague-Dawley rats treated with PCP (4.5 mg/kg, intraperitoneal, twice a day for 7 consecutive days) or saline were tested in behavioral and cognitive tasks 7 days after injections. The PCP group showed increased amphetamine (1.5 mg/kg)-stimulated locomotor activity, and exhibited a greater number of errors in the double Y-maze memory task, when compared with controls. Subchronic PCP treatment increased [H]muscimol-binding sites and decreased affinity for [H]muscimol binding in frontal cortex, hippocampus, and striatum in comparison with controls. There were no changes in the expression of glutamic acid decarboxylase or the GABA membrane transporter protein. These data show that subchronic PCP administration induces an impaired performance of a previously learned task and an enhanced response to amphetamine in the rat. The observed changes in GABAA receptors in the rat brain are consistent ...Continue Reading

References

Dec 6, 1991·Science·J W OlneyM A Sesma
Apr 1, 1991·Brain Research Bulletin·S L BigganR J Boegman
Jan 1, 1988·Schizophrenia Bulletin·T E Goldberg, D R Weinberger
Sep 1, 1988·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Carlsson
Aug 1, 1972·Archives of General Psychiatry·S H Snyder
Dec 1, 1995·Archives of General Psychiatry·J W Olney, N B Farber
Aug 1, 1995·Schizophrenia Research·D R Weinberger, B K Lipska
May 22, 1994·The Journal of Comparative Neurology·A E HendricksonA J Tobin
Sep 7, 1993·European Journal of Pharmacology·X M GaoC A Tamminga
Aug 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D JentschR H Roth
Jun 18, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D JentschR H Roth
Mar 4, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D Jentsch, R H Roth
Apr 26, 2000·British Journal of Pharmacology·U SchroederB A Sabel
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·A Abi-DarghamM Laruelle
Dec 7, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D Jentsch, J R Taylor
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·A CarlssonM L Carlsson
May 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F M Benes, S Berretta
Aug 23, 2002·Behavioural Brain Research·Mark Renato Stefani, Bita Moghaddam
Jul 1, 1962·The American Journal of Psychiatry·E D LUBYE F DOMINO
Jun 19, 2004·Psychopharmacology·Deanna M Barch
Dec 22, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shuzo AbeHeii Arai
Jan 22, 2005·Current Opinion in Pharmacology·Brian J MorrisJudith A Pratt
Mar 25, 2005·The European Journal of Neuroscience·Joshua S RodeferMark G Baxter
May 25, 2006·European Journal of Human Genetics : EJHG·Brien Riley, Kenneth S Kendler
Nov 15, 2006·Behavioural Brain Research·Marie-Claude AudetFrançois Y Doré
Jan 11, 2007·Annual Review of Pharmacology and Toxicology·Annette E FleckensteinGlen R Hanson
Sep 7, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kenji HashimotoMasaomi Iyo
Sep 22, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yuko FujitaKenji Hashimoto
Dec 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cheng Z WangKenneth M Johnson
Dec 21, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua S RodeferJørn Arnt
Jan 1, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hiroko HagiwaraKenji Hashimoto
Mar 4, 2008·British Journal of Pharmacology·J A PrattB J Morris

❮ Previous
Next ❯

Citations

Sep 10, 2011·Journal of Neural Transmission·Sara K OlssonSophie Erhardt
Sep 24, 2015·Molecular Psychiatry·M A Landek-SalgadoA Sawa
Aug 20, 2010·Schizophrenia Research·Emily R HawkenRichard J Beninger
May 3, 2016·Journal of Clinical and Experimental Neuropsychology·Saleh M H MohamedJaap J van der Meere
Jun 16, 2015·British Journal of Pharmacology·D Lodge, M S Mercier
Jan 28, 2017·Frontiers in Cellular Neuroscience·Lamine BouamranePascale Chavis
Oct 19, 2011·Basic & Clinical Pharmacology & Toxicology·Joacim GötessonChris Pickering
Apr 1, 2011·British Journal of Pharmacology·C A JonesK C F Fone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.